{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T04:17:23Z","timestamp":1780373843180,"version":"3.54.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,26]],"date-time":"2025-01-26T00:00:00Z","timestamp":1737849600000},"content-version":"vor","delay-in-days":25,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1124\/jpet.124.002264","type":"journal-article","created":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T15:35:15Z","timestamp":1717774515000},"page":"100005","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Discovery of aurovertin B as a potent metastasis inhibitor against triple-negative breast cancer: Elucidating the complex role of the ATF3-DUSP1 axis"],"prefix":"10.1016","volume":"392","author":[{"given":"Jian-Jun","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Cui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru-Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Yan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Ting","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zha-Jun","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7229-2047","authenticated-orcid":false,"given":"Rui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.124.002264_bib1","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/sj.onc.1209781","article-title":"Induction of activating transcription factor 3 by anoxia is independent of p53 and the hypoxic HIF signalling pathway","volume":"26","author":"Ameri","year":"2007","journal-title":"Oncogene"},{"key":"10.1124\/jpet.124.002264_bib2","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1038\/sj.onc.1202676","article-title":"Fluorescent cDNA microarray hybridization reveals complexity and heterogeneity of cellular genotoxic stress responses","volume":"18","author":"Amundson","year":"1999","journal-title":"Oncogene"},{"key":"10.1124\/jpet.124.002264_bib3","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.bbrc.2009.04.051","article-title":"Molecular mechanisms controlling E-cadherin expression in breast cancer","volume":"384","author":"Baranwal","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/jpet.124.002264_bib4","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJMoa2028485","article-title":"Sacituzumab govitecan in metastatic triple-negative breast cancer","volume":"384","author":"Bardia","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1124\/jpet.124.002264_bib5","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrclinonc.2016.66","article-title":"Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease","volume":"13","author":"Bianchini","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1124\/jpet.124.002264_bib6","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrc865","article-title":"Dissemination and growth of cancer cells in metastatic sites","volume":"2","author":"Chambers","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1124\/jpet.124.002264_bib7","doi-asserted-by":"crossref","first-page":"43091","DOI":"10.1074\/jbc.M111.295865","article-title":"Progesterone receptor inhibits proliferation of human breast cancer cells via induction of MAPK phosphatase 1 (MKP-1\/DUSP1)","volume":"286","author":"Chen","year":"2011","journal-title":"J\u00a0Biol Chem"},{"key":"10.1124\/jpet.124.002264_bib8","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ejca.2003.08.007","article-title":"Wide metastatic spreading in infiltrating lobular carcinoma of the breast","volume":"40","author":"Ferlicot","year":"2004","journal-title":"Eur J Cancer"},{"key":"10.1124\/jpet.124.002264_bib9","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1056\/NEJMra1001389","article-title":"Triple-negative breast cancer","volume":"363","author":"Foulkes","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1124\/jpet.124.002264_bib10","first-page":"5195","article-title":"E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas","volume":"55","author":"Graff","year":"1995","journal-title":"Cancer Res"},{"key":"10.1124\/jpet.124.002264_bib11","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3727\/096504018X15150662230295","article-title":"Emodin inhibits colon cancer cell invasion and migration by suppressing epithelial-mesenchymal transition via the Wnt\/\u03b2-catenin pathway","volume":"27","author":"Gu","year":"2019","journal-title":"Oncol Res"},{"key":"10.1124\/jpet.124.002264_bib12","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/350359a0","article-title":"A\u00a0Tyr\/Ser protein phosphatase encoded by vaccinia virus","volume":"350","author":"Guan","year":"1991","journal-title":"Nature"},{"key":"10.1124\/jpet.124.002264_bib13","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1007\/s00268-012-1608-y","article-title":"Decreased total MKP-1 protein levels predict poor prognosis in breast cancer","volume":"36","author":"Hou","year":"2012","journal-title":"World J Surg"},{"issue":"Suppl 1","key":"10.1124\/jpet.124.002264_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1634\/theoncologist.2011-S1-01","article-title":"Triple-negative breast cancer: an unmet medical need","volume":"16","author":"Hudis","year":"2011","journal-title":"Oncologist"},{"key":"10.1124\/jpet.124.002264_bib15","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2217\/pgs-2017-0117","article-title":"Triple-negative breast cancer and the potential for targeted therapy","volume":"18","author":"Jhan","year":"2017","journal-title":"Pharmacogenomics"},{"key":"10.1124\/jpet.124.002264_bib16","first-page":"594","article-title":"Frequent down-regulation of E-cadherin by genetic and epigenetic changes in the malignant progression of hepatocellular carcinomas","volume":"7","author":"Matsumura","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1124\/jpet.124.002264_bib17","doi-asserted-by":"crossref","first-page":"5931","DOI":"10.1073\/pnas.1918167117","article-title":"The functional activity of E-cadherin controls tumor cell metastasis at multiple steps","volume":"117","author":"Na","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.124.002264_bib18","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","article-title":"Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019","volume":"83","author":"Newman","year":"2020","journal-title":"J\u00a0Nat Prod"},{"key":"10.1124\/jpet.124.002264_bib19","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrc2131","article-title":"Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?","volume":"7","author":"Peinado","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1124\/jpet.124.002264_bib20","article-title":"Correction: Androgen receptor (AR), E-cadherin, and Ki-67 as emerging targets and novel prognostic markers in triple-negative breast cancer (TNBC) patients","volume":"10","author":"Ricciardi","year":"2015","journal-title":"PLoS One"},{"key":"10.1124\/jpet.124.002264_bib21","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMoa1706450","article-title":"Olaparib for metastatic breast cancer in patients with a germline BRCA mutation","volume":"377","author":"Robson","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1124\/jpet.124.002264_bib22","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1002\/cam4.772","article-title":"Role of DUSP1\/MKP1 in tumorigenesis, tumor progression and therapy","volume":"5","author":"Shen","year":"2016","journal-title":"Cancer Med"},{"key":"10.1124\/jpet.124.002264_bib23","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/carcin\/24.2.225","article-title":"Response of human mammary epithelial cells to DNA damage induced by BPDE: involvement of novel regulatory pathways","volume":"24","author":"Wang","year":"2003","journal-title":"Carcinogenesis"},{"key":"10.1124\/jpet.124.002264_bib24","first-page":"261","article-title":"Aurovertin B exerts potent antitumor activity against triple-negative breast cancer in\u00a0vivo and in\u00a0vitro via regulating ATP synthase activity and DUSP1 expression","volume":"75","author":"Wu","year":"2020","journal-title":"Pharmazie"},{"key":"10.1124\/jpet.124.002264_bib25","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.3390\/ijms22052353","article-title":"ATF3-induced mammary tumors exhibit molecular features of human basal-like breast cancer","volume":"22","author":"Yan","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1124\/jpet.124.002264_bib26","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1038\/sj.onc.1210861","article-title":"A\u00a0potential dichotomous role of ATF3, an adaptive-response gene, in cancer development","volume":"27","author":"Yin","year":"2008","journal-title":"Oncogene"},{"key":"10.1124\/jpet.124.002264_bib27","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1242\/jcs.064915","article-title":"ATF3, an adaptive-response gene, enhances TGF\u03b2 signaling and cancer-initiating cell features in breast cancer cells","volume":"123","author":"Yin","year":"2010","journal-title":"J\u00a0Cell Sci"},{"key":"10.1124\/jpet.124.002264_bib28","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/hlca.201600026","article-title":"Aurovertin-type polyketides from Calcarisporium arbuscula with potent cytotoxic activities against triple-negative breast cancer","volume":"99","author":"Zhao","year":"2016","journal-title":"Helvetica Chimica Acta"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524000247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524000247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.124.002264","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T20:42:06Z","timestamp":1740343326000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524000247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0022356524000247"],"URL":"https:\/\/doi.org\/10.1124\/jpet.124.002264","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of aurovertin B as a potent metastasis inhibitor against triple-negative breast cancer: Elucidating the complex role of the ATF3-DUSP1 axis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.124.002264","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"100005"}}